Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Cash & Current Investments: 2020-2023

Historic Cash & Current Investments for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $158.9 million.

  • Therapeutics' Cash & Current Investments fell 47.01% to $97.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $513.2 million, marking a year-over-year decrease of 41.05%. This contributed to the annual value of $158.9 million for FY2023, which is 36.22% down from last year.
  • As of FY2023, Therapeutics' Cash & Current Investments stood at $158.9 million, which was down 36.22% from $249.1 million recorded in FY2022.
  • Over the past 5 years, Therapeutics' Cash & Current Investments peaked at $249.1 million during FY2022, and registered a low of $111.5 million during FY2020.
  • For the 3-year period, Therapeutics' Cash & Current Investments averaged around $199.2 million, with its median value being $189.7 million (2021).
  • As far as peak fluctuations go, Therapeutics' Cash & Current Investments surged by 70.08% in 2021, and later crashed by 36.22% in 2023.
  • Therapeutics' Cash & Current Investments (Yearly) stood at $111.5 million in 2020, then surged by 70.08% to $189.7 million in 2021, then surged by 31.33% to $249.1 million in 2022, then crashed by 36.22% to $158.9 million in 2023.